Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 3
1964 2
1965 1
1966 3
1967 3
1968 3
1970 1
1972 1
1973 1
1974 1
1975 1
1976 4
1977 3
1978 4
1979 2
1980 2
1981 6
1982 3
1983 1
1985 3
1986 1
1988 2
1989 4
1990 5
1991 6
1992 7
1993 9
1994 15
1995 11
1996 18
1997 11
1998 20
1999 21
2000 26
2001 40
2002 45
2003 29
2004 44
2005 49
2006 38
2007 49
2008 87
2009 106
2010 107
2011 111
2012 128
2013 143
2014 130
2015 159
2016 131
2017 124
2018 122
2019 138
2020 129
2021 135
2022 121
2023 150
2024 129
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,367 results

Results by year

Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.
Konstantinopoulos PA, Waggoner S, Vidal GA, Mita M, Moroney JW, Holloway R, Van Le L, Sachdev JC, Chapman-Davis E, Colon-Otero G, Penson RT, Matulonis UA, Kim YB, Moore KN, Swisher EM, Färkkilä A, D'Andrea A, Stringer-Reasor E, Wang J, Buerstatte N, Arora S, Graham JR, Bobilev D, Dezube BJ, Munster P. Konstantinopoulos PA, et al. Among authors: kim yb. JAMA Oncol. 2019 Aug 1;5(8):1141-1149. doi: 10.1001/jamaoncol.2019.1048. JAMA Oncol. 2019. PMID: 31194228 Free PMC article.
Exercising insulin sensitivity: AMPK turns on autophagy!
Dagon Y, Mantzoros C, Kim YB. Dagon Y, et al. Among authors: kim yb. Metabolism. 2015 Jun;64(6):655-7. doi: 10.1016/j.metabol.2015.03.002. Epub 2015 Mar 14. Metabolism. 2015. PMID: 25819737 Free PMC article. No abstract available.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.
Marth C, Moore RG, Bidziński M, Pignata S, Ayhan A, Rubio MJ, Beiner M, Hall M, Vulsteke C, Braicu EI, Sonoda K, Wu X, Frentzas S, Mattar A, Lheureux S, Chen X, Hasegawa K, Magallanes-Maciel M, Choi CH, Shalkova M, Kaen D, Wang PH, Berger R, Okpara CE, McKenzie J, Yao L, Orlowski R, Khemka V, Gilbert L, Makker V; ENGOT-en9/LEAP-001 Investigators. Marth C, et al. J Clin Oncol. 2024 Nov 26:JCO2401326. doi: 10.1200/JCO-24-01326. Online ahead of print. J Clin Oncol. 2024. PMID: 39591551
Hypothalamic Microglial Activation in Obesity: A Mini-Review.
Mendes NF, Kim YB, Velloso LA, Araújo EP. Mendes NF, et al. Among authors: kim yb. Front Neurosci. 2018 Nov 15;12:846. doi: 10.3389/fnins.2018.00846. eCollection 2018. Front Neurosci. 2018. PMID: 30524228 Free PMC article. Review.
Targeting nrf2 signaling to combat chemoresistance.
No JH, Kim YB, Song YS. No JH, et al. Among authors: kim yb. J Cancer Prev. 2014 Jun;19(2):111-7. doi: 10.15430/JCP.2014.19.2.111. J Cancer Prev. 2014. PMID: 25337579 Free PMC article. Review.
Urgent Action on Tackling Antibiotic Resistance.
Lee JH, Kim TY, Malik SK, Jeon JH, Kim YB, Lee SH. Lee JH, et al. Among authors: kim yb. Iran J Public Health. 2021 Sep;50(9):1902-1903. doi: 10.18502/ijph.v50i9.7064. Iran J Public Health. 2021. PMID: 34722387 Free PMC article. No abstract available.
Ambient air pollution and movement behaviours: A scoping review.
Kim YB, McCurdy AP, Lamboglia CG, Hakimi S, Kuzik N, Lee EY, Lindeman C, Sivak A, Spence JC. Kim YB, et al. Health Place. 2021 Nov;72:102676. doi: 10.1016/j.healthplace.2021.102676. Epub 2021 Oct 23. Health Place. 2021. PMID: 34700061 Review.
2,367 results